Please login to the form below

Not currently logged in


This page shows the latest gantenerumab news and features for those working in and with pharma, biotech and healthcare.

Double blow to amyloid drug hopes as Roche, Lilly trial fails

Double blow to amyloid drug hopes as Roche, Lilly trial fails

At the same time, another arm of the study testing Roche’s gantenerumab also ended in failure in DIAD – also known as autosomal dominant Alzheimer’s disease (ADAD) – which accounts for ... Solanezumab works by binding to soluble amyloid beta,

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....